Ontology highlight
ABSTRACT: Background
The additional monitoring (AM)/black triangle concept is aimed to enhance ADR reporting for certain types of medicinal products for which the safety profile is less well established.Purpose
The objective of this survey was to assess (a) attitudes towards ADR reporting and reasons for not reporting an ADR and (b) awareness of AM among HCPs, patients or their careers in EU countries.Methods
An online questionnaire which was available in all EU languages was completed by 2918 responders coming from all EEA countries.Results
The main factors motivating to report an ADR were severity or novelty of the reaction or novelty of the medicine. The main factors for not reporting an ADR was the fact that the ADR is already known (35%), the ADR was not serious
SUBMITTER: Januskiene J
PROVIDER: S-EPMC7894330 | biostudies-literature | 2021 Mar
REPOSITORIES: biostudies-literature